From: TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma
Variables | Univariate Cox analysis | Multivariate Cox analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (≥60 vs. < 60) | 1.83(0.79–4.27) | 0.157 | 10.33(2.20–48.61) | 0.003** |
Gender (male vs. female) | 1.54(0.65–3.65) | 0.325 | 0.95(0.29–3.11) | 0.938 |
Histological type (Mixed vs. Others) | 1.67(0.72–3.88) | 0.232 | 0.33(0.11–0.98) | 0.045* |
Stage (III + IV vs. I + II) | 1.72(0.70–4.19) | 0.234 | 3.82(1.13–12.91) | 0.031* |
Type (metastatic vs. non- metastatic) | 25.10(7.39–85.20 | < 0.001*** | 75.28(15.92–355.91) | < 0.001*** |
TAP1 (high vs. low) | 3.23(1.32–7.91) | 0.010* | 1.43(0.53–3.87) | 0.484 |